Genomeditech

🧬 Looking to get more value out of your research this season? This April, Enjoy free shipping + exclusive discounts with every quote of Genomeditech en.genomeditech.com/cell-line #ReporterCellLines #Biotech #DrugDiscovery

🧬 FDA-approved Foundayo™ (Orforglipron) brings oral GLP-1 therapy to obesity research. Explore small-molecule GLP-1 studies with Genomeditech’s GLP1R cell & reporter lines. 🔗 en.genomeditech.com/cell-line/GPCR #ObesityResearch #GLP1 #CellLines #DrugDiscovery

Accelerate ADC research with ready-to-use reporter cell lines: • Streamline functional assays • Boost reproducibility • Focus on drug optimization Learn more 👉 en.genomeditech.com/cell-line/Anti… #ADC #DrugDevelopment #CellLineTools

Two IL-17A cell line solutions, one target. 🧪 Reporter HEK293 → Functional Validation 🧬 Membrane-Bound CHO-K1 → Target Engagement From signaling to binding, accelerate IL-17A research! en.genomeditech.com/cell-line/Cyto… #IL17A #CellLine #DrugDiscovery #Bioassay

🔬 ADC Discovery Month – March 2026 Genomeditech is offering ADC-related cell lines starting at 20% OFF, plus a free antibody or protein trial to support ADC research. Accelerate your ADC discovery 👇 en.genomeditech.com/cell-line #ADC #DrugDiscovery #CellLines #Biotech

Attending BIOCHINA 2026 in Suzhou? 🔬 Visit Genomeditech at Booth F3B72 (Mar 12–14) and meet our global team to discuss cell lines and customized solutions for your research. 💬 Let’s accelerate discovery together. #BIOCHINA2026 #Biotech #CellLines #LifeScience

🚀 ADC Month at Genomeditech! Selected ADC cell lines from 20% off + free antibody/protein trial samples. Boost target validation & functional studies now 👉 en.genomeditech.com/v2/activity/de… #ADC #Biotech #CellLines #Genomeditech

FDA grants accelerated approval to zongertinib (Hernexeos) for HER2-mutant unresectable or metastatic nonsquamous NSCLC. Genomeditech offers HER2 cell line models to support preclinical research. 🔗 en.genomeditech.com/cell-line/Kina… #NSCLC #HER2 #TargetedTherapy #PreclinicalResearch

Genomeditech is back after the Chinese New Year 🧬✨ Labs are running, projects are moving, and the focus remains on supporting researchers with reliable cell models. Let’s accelerate discovery together 🚀 #BackToWork #Biotech #ResearchTools #PreclinicalResearch #Genomeditech

🧧 Happy Chinese New Year from Genomeditech Welcoming the Year of the Horse with energy, momentum, and gratitude for continued trust. Holiday: Feb 15–23 | Operations resume Feb 24. Wishing a prosperous year ahead. #ChineseNewYear #LunarNewYear #YearOfTheHorse #Genomeditech

🧬 Luciferase HEK-293 Cell Line (GM-C36959) Engineered for in vivo bioluminescence imaging, enabling sensitive, real-time tracking of cellular activity in live models. Stable luciferase expression supports reliable preclinical research. 🔗 en.genomeditech.com/cell-line/Luci… #InVivoImaging

🧬 Reliable cellular models for IL-23 pathway research. Genomeditech’s pre-made IL-23 cell lines support consistent signaling and reproducible preclinical data. Explore more 👉 en.genomeditech.com/cell-line/Cyto… #Genomeditech #IL23 #CytokineBiology #DrugDiscovery

🧬 Explore TNF signaling with precision! H_TNFR2 Reporter V2 ✅ TNFR2-only H_TNFR2 Null ✅ TNFR1-only Part of our TNF cell line series for receptor-specific research & drug discovery. 🔗 en.genomeditech.com/cell-line/TNF%… #TNF #CellLineResearch #BiotechTools

We want to hear from you! 🧬 Why do high-quality cell lines matter in research? 💬 Comment your reason & get a 20% discount code! 🔗 Learn more: en.genomeditech.com/news/detail?id… #CellLines #LifeScienceResearch #BiomedicalResearch

TNF-α: Renewed Focus in Autoimmune Disease Therapy linkedin.com/pulse/tnf-%CE%…

🎗️ World Cancer Day Every question in cancer research leads to a life. By providing reliable cell lines, proteins, and antibodies, we empower researchers to turn insights into potential therapies. Strong science, real impact. #WorldCancerDay #CancerResearch #LifeSciences

CagriSema (amylin + GLP-1) achieved 14.2% weight loss and 1.91% HbA1c reduction in REIMAGINE 2, outperforming semaglutide. GLP-1 & amylin convergence highlights the need for MOA-relevant cell models in metabolic drug discovery. en.genomeditech.com/cell-line/GPCR #GLP1 #Amylin

🔬 PD-1 agonists are opening new paths in autoimmune research. Genomeditech’s PD-1 cell lines are stable, QC-validated, and ready for in vitro studies & drug discovery. Explore: en.genomeditech.com/cell-line/Immu… #PD1 #Immunotherapy #Autoimmune #CellLine #Biotech

PD-1 Agonists: Insights into Their Growing Impact linkedin.com/pulse/pd-1-ago…

🔬 Last Call | Reporter & Expression Cell Lines Up to 40% OFF selected models ✔ Stable & reproducible ✔ Broad target coverage ⏰ Ends Jan 31 👉 en.genomeditech.com/cell-line #ReporterCellLines #ExpressionCellLines #DrugDiscovery #Preclinical #Biotech